ArticleTranslational cancer research2026
Global research trends in oncolytic virotherapy for sarcomas of bone and soft tissue (2000-2024): a bibliometric and visualization study.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oncolytic viruses (OVs) represent a class of naturally occurring or genetically engineered viruses that selectively infect and lyse tumor cells while sparing normal tissues. Sarcomas of bone and soft tissue are malignant neoplasms originating from mesenchymal tissues, encompassing a wide spectrum of pathological subtypes. Current standard treatments primarily involve surgical resection, radiotherapy, and neoadjuvant chemotherapy, with oncolytic virotherapy emerging as a promising therapeutic approach in this field. Methods: The Web of Science Core Collection was comprehensively searched for literature on oncolytic virotherapy for bone and soft tissue sarcomas. After filtering, a total of 192 articles published between January 1, 2000, and December 31, 2024, were included in the final analysis. A bibliometric analysis was performed for the evaluation of multiple dimensions, including international collaboration, country and institutional contributions, publishing journals, authorship, keyword co-occurrence, reference patterns, citation counts, research topics, and publication chronology. Results: The most cited article was authored by E. Galanis Conclusions: The current study analyzed 192 publications concerning oncolytic virotherapy for bone and soft tissue sarcomas over the past 25 years. This information identifies recent research frontiers and hot directions, which would provide a reference for scholars studying oncolytic virotherapy for sarcomas of bone and soft tissue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.